Melatonin attenuates methamphetamine-induced neuroinflammation through the melatonin receptor in the SH-SY5Y cell line
| Autor: | Pawaris Wongprayoon, Piyarat Govitrapong |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
medicine.medical_specialty
Time Factors SH-SY5Y Receptors Melatonin Pharmacology Biology Transfection Toxicology Melatonin receptor Antioxidants Culture Media Serum-Free Methamphetamine Melatonin Neuroblastoma Cell surface receptor Cell Line Tumor Internal medicine medicine Humans RNA Small Interfering Receptor Neuroinflammation Inflammation Tumor Necrosis Factor-alpha General Neuroscience Tryptamines Gene Expression Regulation Neoplastic Protein Transport Endocrinology Central Nervous System Stimulants I-kappa B Proteins Luzindole medicine.drug |
| Zdroj: | NeuroToxicology. 50:122-130 |
| ISSN: | 0161-813X |
| Popis: | Methamphetamine is a well-known psychostimulant drug, the abuse of which is a serious worldwide public health issue. In addition to its addictive effect, methamphetamine exposure has been shown to be associated with neuroinflammation in several brain areas. Several lines of evidence indicate that TNFα plays an important role in the methamphetamine-induced neuroinflammatory processes that result in apoptotic cell death. Many investigators have demonstrated the anti-neuroinflammatory effects of melatonin, but the mechanism by which this occurs still needs to be explored. In this study, we investigated the effect of methamphetamine on TNFα expression and NFκB activation in the neuroblastoma cell line SH-SY5Y. We demonstrated the time-dependent effect of methamphetamine on the induction of TNFα expression as well as IκB degradation and NFκB nuclear translocation. Furthermore, we investigated the effect of melatonin on methamphetamine-induced TNFα overexpression and NFκB activation. The results showed that pretreatment with 100nM melatonin could prevent the TNFα overexpression caused by methamphetamine exposure. This attenuating effect was prevented by pre-incubation with luzindole, an antagonist of the melatonin MT1/MT2 receptors. Furthermore, methamphetamine-induced IκB degradation and NFκB nuclear translocation were also suppressed by pretreatment with melatonin, and pretreatment with luzindole diminished these protective effects. MT2 knockdown by siRNA abrogated the anti-inflammatory effect exerted by melatonin. From these findings, we propose that melatonin exerts its protective effects on methamphetamine-induced neuroinflammation through the membrane receptor, at least in part MT2 subtype, in the SH-SY5Y neuroblastoma cell line. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect